Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. Lindhofer
The Trifunctional Antibody Ertumaxomab Destroys Tumor Cells That Express Low Levels of Human Epidermal Growth Factor Receptor 2
Cancer Research
Cancer Research
Oncology
Related publications
The Synergistic Antitumor Effect of Combined Anti-Human Epidermal Growth Factor Receptor 2 Antibody and Gamma Interferon Therapy on Antibody-Resistant Breast Cancer Cells
The Showa University Journal of Medical Sciences
Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer
Cancer Control
Medicine
Oncology
Hematology
Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas
American Journal of Pathology
Forensic Medicine
Pathology
Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Epidermal Growth Factor Receptor in Human Glioma
Journal of Neurosurgery
Surgery
Neurology
Herceptin Enhances the Antitumor Effect of Natural Killer Cells on Breast Cancer Cells Expressing Human Epidermal Growth Factor Receptor-2
Frontiers in Immunology
Allergy
Immunology
CD9 Modulates Proliferation of Human Glioblastoma Cells via Epidermal Growth Factor Receptor Signaling
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy
Oncology Reports
Medicine
Cancer Research
Oncology
Mammary Tumors That Become Independent of the Type I Insulin-Like Growth Factor Receptor Express Elevated Levels of Platelet-Derived Growth Factor Receptors
BMC Cancer
Cancer Research
Oncology
Genetics
